How's bout 'Butchie's Bedtime Brothel' where our girls leave you with a smile. Open 24/7 come 1 come all, come agane, agane and AGANE!
Rory,,I gave up trying to catch a pump-n-dump here. It just never happens at the right time. Look at last week. over 10M in volume one day to go up a nickle only to decline back to lows just like always. Its the ANX/MAST way with the SP. Never fails!! I respect Brendan's position as well but i feel his pain
You have a hateful posting history on this and the ANX board. I invite anyone to do some DD on your history of BASHING and attacking any positive posting message board member, before they take your posts seriously!
4Wheeler,, I invite anyone to review your posts, under all the different alias you have been using in which you have been PUMPING the same infomation for the past 3 years. How much the money the company has on hand 20M, 30M, 40M and now 52M. Institutions buying which they have for years and have NEVER seen a return on the investment. Drug in PH3 stages only to be rejected. You only want to see the positive (if there are any with this company) and never the negative which has been the real TRUTH. As for your comment about being taken seriously, when you invest your hard earned money and believe what a company is telling only to lose over 90% of your wealth, you have every right to be #$%$ off. Yu call it bashing, but people like you, on these boards like to throw that word BASHER around way too often!
I also invite anyone to do DUE DILIGENCE on the ANX and MAST board. Look up the words truth, truth up, over the basher lies and so on, they will see how many years you under many other id's have been promoting this company. I then say look at the charts and they will know your history before ever taking you serious! good day sir!
The NIH determined that the cost-effectiveness of hydroxyurea (measured in hospital cost avoidance) is $5210 per patient. This is the most relevant metric that ANX-188 must outperform if it is to gain acceptance as a prescription drug after its Phase 3 trials. Hydroxyurea is a prescription-only drug available now in generic form, and a quick web search shows per-pill prices of US$0.55 to $1.42 depending on the pharmacy.
ANX-188 needs to be both a qualitatively superior treatment and competitively priced to have a shot at taking on hydroxyurea. It's hospitalization cost avoidance must be greater than $5210 per patient and the dosage should cost less than a buck at retail. This company's name change is the beginning of a new story for their drugs. There's nothing like a clean break with the past if you want to focus on the future.
**We shall see, We shall see!
'There will be now $.50 to $10.00 any time soon'
Correction ** There will not be any change in SP from $0.50to $10 bucks anytime soon. hard to type on this cell phone. Now do you understand ole boy. I feel for people like you who have been burned by this company. I know, I was you not very long ago. I sold and ended my losses here for good. And I DO have the right to my opinion which is based on the companies history and preformance, but also based on the amount of money I lost having hope and dreams here!!
Sentiment: Strong Sell
Correction ** but the charts and facts which include a rejected drug 3 years AGO.
Not bashing or #$%$ in anyone's Corn Flakes, but this is the truth. I would love to see a SCD on the market helping people. I would love to see any type of cancer fighting drug on the market, JMHO, politics will not allow that to happen and even if it did, it would not be Mast (MSTX)
Sentiment: Strong Sell
For starters, Mast Therapeutics, INC, is not a start up company. The company formerly known as Adventrx Pharmaceuticals and multiple names before that was started in 1995. No drugs have ever been approved under the management of this company, nor will any EVER be approved. There are people here who are holding the stock since before the reverse split of 2010. They want you to believe the Mast will find cure for SCD by producing MST 188, but these same individuals were PUMPING ANX 530 and some even Cofactor. There are so many companies that have been in existance for 20 or 30 plus years promoting the same thing, alll the while forcing the company todo reverse splits, diluting the companies stock all the while never bringing a life saving drug to the market to save lives or help people. It is all about the almight dollar and milking shareholders for every nickle and dime. Look no further that CelSci (CVM) with Multikine and Genta Corporation (GNTAQ) with Genasense. Both companies milked shareholders for over 25 years. I see no difference here with Mast Therapeutics. I will be called names by longs who are painfully suffering but the charts and facts which include a rejected drug 3 years are the real TRUTH!! So all you swing traders who claim this is going to shoot to the moon so to speak, keep making your change,that is all your going to make here. There will be now .$.50 to $10.00 any time soon!
A former investor who was burned bad by this company
Sentiment: Strong Sell